castlecreekpharma.com
Castle Creek Pharmaceuticals Appoints Mary Spellman, M.D., as Chief Medical Officer and Senior Vice President of Research & Development
PARSIPPANY, N.J., June 3, 2019 -- Castle Creek Pharmaceuticals, LLC., a privately held biopharmaceutical company developing innovative therapies for patients with rare, serious or debilitating dermatologic conditions, today announced the appointment of Mary Spellman, M.D., as Chief Medical Officer and Senior Vice President of Research & Development of Castle Creek. "We are pleased